Neil Miller, MD
Disclosures: Study Director for QRK207 Clinical Treatment Trial for NAION-Quark Pharmaceuticals-Other_Role-I am the study director of a prospective, placebo-controlled, masked, randomized clinical treatment trial for acute non-arteritic anterior ischemic optic neuropathy. |Consulting Fee-Regenera-Other_Role-I am a compensated consultant for a planned prospective, placebo-controlled, masked, randomized clinical treatment trial for previous non-arteritic anterior ischemic optic neuropathy
No Bio Available.